Healthtech Startups
16,988 companies tagged Healthtech, with their investors and founders.
Sionna Therapeutics is a biopharmaceutical company founded in 2019 that develops small-molecule therapies for cystic fibrosis by targeting and stabilizing NBD1, the domain of the CFTR protein where the common ΞF508 mutation occurs. It is advancing a portfolio of NBD1 stabilizers and complementary CFTR modulators intended to be used in combination to normalize CFTR function in CF patients.
2 investors
SIQ (now Spalding TF DNA) develops smart basketballs equipped with sensor technology that track performance metrics. The product is designed for basketball players and coaches.
2 investors
Sirius NeoSight develops a patented technology that measures cell membrane fluidity using a fluorescent molecule to detect, isolate and characterise Circulating Tumour Cells (CTCs) from blood samples. Aimed at oncologists, the technology supports early cancer detection, monitoring of recurrence and treatment resistance, and personalised therapy selection for metastatic and aggressive cancers.
2 investors
Sirius Therapeutics is a biopharmaceutical company developing siRNA-based therapeutics, including work in the anti-coagulant therapeutic area. It focuses on drug discovery and clinical development of RNA-based medicines.
2 investors
SiSaf is an RNA delivery and therapeutics company that uses its proprietary bioabsorbable silicon-based Bio-Courier technology to deliver nucleic acids, avoiding the ultra-cold supply chain of conventional lipid nanoparticles. It is developing a pipeline of RNA therapeutics targeting pancreatic cancer, metastatic cancer, and the rare skeletal disease osteopetrosis ADO2.
2 investors
2 investors
SiteRx works to make clinical research more accessible by improving transparency and diversity in clinical trials, connecting patients with research opportunities for their medical conditions. The company focuses on bringing treatments to market more efficiently, with a stated interest in Alzheimer's disease research.
2 investors
Sixfold develops RNA delivery technology for the biotech industry. The company was founded by an oncologist and plant scientist and focuses on advancing RNA-based therapeutic approaches through proprietary delivery methods.
2 investors
SkinCheck develops a computer vision AI app that analyzes skin images to detect potential signs of skin cancer early, providing users with instant feedback and recommendations. It is designed to work across all skin colors and is aimed at individuals globally, with a focus on reducing health inequity in skin cancer detection.
2 investors
Skylabs makes CART BP, a ring-shaped blood pressure monitor worn on the finger that automatically measures systolic/diastolic blood pressure and pulse using PPG (photoplethysmography), including during sleep. It is a certified medical device aimed at people managing hypertension at home, with data synced to a companion app for daily, weekly, and monthly tracking.
2 investors
Slope provides software to manage the biospecimen lifecycle for clinical research sites, enabling researchers and sponsors to track and oversee biological samples at scale throughout clinical trials. The platform serves clinical research sites, sponsors, and contract research organizations conducting clinical trials.
2 investors
smallTalk develops technology products that support early childhood brain development through language exposure. The company targets parents and caregivers of infants and young children in the early development market.
2 investors
Smartlens develops wearable microfluidic devices and AI-powered platforms for remote monitoring and diagnosis of anterior segment eye diseases, particularly glaucoma. The company's flagship product, miLens, is a contact lens for continuous intraocular pressure monitoring.
2 investors
SmartyPants makes vitamins and nutritional supplements formulated for kids and adults, including gummy multivitamins, sold direct-to-consumer and through retailers like Amazon. The company offers an auto-delivery subscription program and focuses on science-backed, good-tasting formulas.
2 investors
Smile2Impress provides invisible orthodontic treatments using clear aligner technology for patients seeking to straighten their teeth. The company operates through a network of clinics across multiple countries and offers flexible financing options starting at β¬43.89 per month.
2 investors
Kii Health provides employee health navigation services that guide workers through complex healthcare decisions by connecting them with appropriate professionals and care pathways to improve outcomes and reduce organizational risk.
2 investors
Softheon provides technology for health insurance plans and government agencies to manage shopping, enrollment, billing, payments, and analytics across ACA Marketplace, Medicare Advantage, and ICHRA coverage. The company serves health plans and state and federal agencies in the United States within the health insurance and healthtech sector.
2 investors
Sofwave develops non-invasive medical aesthetic devices using next-generation technology for skin revitalization, muscle toning, and facial treatments. The company serves aesthetic practices and clinics seeking FDA-cleared solutions for wrinkle reduction, skin laxity, and body contouring.
2 investors
Soihtu DTx develops a clinical-stage digital therapeutic delivered as a narrative-driven video game designed to treat depression. The product is personalized using precision psychiatry principles and has been validated in large-scale clinical trials.
2 investors
Solabia is a producer of raw materials including ingredients, active ingredients, culture media, and diagnostic kits for the cosmetics, pharmaceutical, nutraceutical, and biotechnology industries. The group serves manufacturers in these sectors with a focus on innovation, sustainability, and responsible growth.
2 investors
Solarea Bio develops plant-sourced living synbiotics (probiotics plus prebiotics) as medical foods targeting inflammatory conditions, starting with bone loss in women with osteopenia. Its clinically tested products aim to address underserved conditions such as osteopenia and rheumatoid arthritis.
2 investors
Solaxa is a biotech company developing pharmacological and cell-based treatments for peripheral nerve injury and spinal cord injury, drawing on regenerative medicine and nerve technologies. It focuses on drug and drug-device combination products in the field of neurology.
2 investors
Solstice Health offers an AI-driven platform for pharmaceutical brand marketing, generating personalized, compliant campaign assets from approved brand libraries and pushing them through regulatory review via integrations such as Veeva. It serves pharma marketing and engagement teams, aiming to move content from brief to MLR submission in days.
2 investors
Solu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.
2 investors